BG
CNMD icon

Bahl & Gaynor’s CONMED CNMD Stock Holding History

Bahl & Gaynor’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,498
Closed -$1.24M – 334
2024
Q1 		$1.24M Buy
15,498
+64
+0.4% +$5.71K 0.01% 237
2023
Q4 		$1.69M Buy
15,434
+207
+1% +$21.4K 0.01% 218
2023
Q3 		$1.54M Buy
15,227
+12
+0.1% +$1.38K 0.01% 218
2023
Q2 		$2.07M Sell
15,215
-15
-0.1% -$1.83K 0.01% 208
2023
Q1 		$1.58M Sell
15,230
-11,984
-44% -$1.16M 0.01% 220
2022
Q4 		$2.41M Sell
27,214
-8,506
-24% -$706K 0.02% 193
2022
Q3 		$2.86M Sell
35,720
-12,482
-26% -$1.18M 0.02% 185
2022
Q2 		$4.62M Buy
48,202
+785
+2% +$94.2K 0.03% 165
2022
Q1 		$7.04M Sell
47,417
-1,383
-3% -$193K 0.05% 135
2021
Q4 		$6.92M Buy
48,800
+85
+0.2% +$12K 0.04% 151
2021
Q3 		$6.37M Buy
48,715
+147
+0.3% +$19.2K 0.04% 149
2021
Q2 		$6.67M Sell
48,568
-3,041
-6% -$416K 0.04% 143
2021
Q1 		$6.74M Buy
51,609
+1,281
+3% +$154K 0.04% 137
2020
Q4 		$5.64M Buy
50,328
+823
+2% +$77.9K 0.04% 139
2020
Q3 		$3.9M Sell
49,505
-1,320
-3% -$108K 0.03% 163
2020
Q2 		$3.66M Buy
50,825
+111
+0.2% +$7.72K 0.03% 162
2020
Q1 		$2.9M Buy
50,714
+13,892
+38% +$1.28M 0.03% 173
2019
Q4 		$4.12M Buy
36,822
+159
+0.4% +$16.9K 0.03% 160
2019
Q3 		$3.52M Buy
36,663
+8,111
+28% +$761K 0.03% 176
2019
Q2 		$2.44M Buy
+28,552
New +$2.35M 0.02% 208

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Bahl & Gaynor's CNMD Position: Q2 2024 in Review

Bahl & Gaynor sold out of CONMED (CNMD) in Q2 2024, closing a stake of 15,498 shares — an estimated $1.24M sold.

Bahl & Gaynor first reported a position in CNMD in Q2 2019 and held it in 20 quarters. The position peaked at $7.04M in Q1 2022. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

  • Bahl & Gaynor reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
  • Bahl & Gaynor sold 15,498 CONMED shares in Q2 2024, an estimated $1.24M.
  • Bahl & Gaynor first reported a position in CONMED in Q2 2019 and held it in 20 quarters.
  • Bahl & Gaynor's CONMED position peaked at $7.04M in Q1 2022.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on Bahl & Gaynor's 13F filing for Q2 2024, filed 7 Aug 2024.